Toll like receptor signaling in "inflammaging": microRNA as new players.

none7nopubblicazione scientificaopenOlivieri F; Rippo MR; Prattichizzo F; Babini L; Graciotti L; Recchioni R; Procopio ADOlivieri, Fabiola; Rippo, Maria Rita; Prattichizzo, Francesco; Babini, Lucia; Graciotti, Laura; Recchioni, R; Procopio, Antonio Domenic

The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents

none12noDisorders of lipoprotein metabolism are among the major risk factors for cardiovascular disease (CVD) development. Single nucleotide polymorphisms (SNPs) have been associated with the individual variability in blood lipid profile and response to lipid-lowering treatments. Here, we genotyped 34 selected SNPs located in coding genes related to lipid metabolism, inflammation, coagulation, and a polymorphism in the MIR499 gene-a microRNA previously linked to CVD-to evaluate the association with lipid trait in subjects with moderate dyslipidemia not on lipid-lowering treatment (Treatment-naïve (TN) cohort, n = 125) and in patients treated with statins (STAT cohort, n = 302). We also explored the association between SNPs and the effect of a novel phytochemical lipid-lowering treatment in the TN cohort. We found that 6 SNPs (in the MIR499, TNFA, CETP, SOD2, and VEGFA genes) were associated with lipid traits in the TN cohort, while no association was found with the response to twelve-week phytochemical treatment. In the STAT cohort, nine SNPs (in the MIR499, CETP, CYP2C9, IL6, ABCC2, PON1, IL10, and VEGFA genes) were associated with lipid traits, three of which were in common with the TN cohort. Interestingly, in both cohorts, the presence of the rs3746444 MIR499 SNP was associated with a more favorable blood lipid profile. Our findings could add information to better understand the individual genetic variability in maintaining a low atherogenic lipid profile and the response to different lipid-lowering therapies.openGiuliani, Angelica; Montesanto, Alberto; Matacchione, Giulia; Graciotti, Laura; Ramini, Deborah; Protic, Olga; Galeazzi, Roberta; Antonicelli, Roberto; Tortato, Elena; Bonfigli, Anna Rita; Sabbatinelli, Jacopo; Olivieri, FabiolaGiuliani, Angelica; Montesanto, Alberto; Matacchione, Giulia; Graciotti, Laura; Ramini, Deborah; Protic, Olga; Galeazzi, Roberta; Antonicelli, Roberto; Tortato, Elena; Bonfigli, Anna Rita; Sabbatinelli, Jacopo; Olivieri, Fabiol

Dystrophin Is Required for the Normal Function of the Cardio-Protective KATP Channel in Cardiomyocytes

Duchenne and Becker muscular dystrophy patients often develop a cardiomyopathy for which the pathogenesis is still unknown. We have employed the murine animal model of Duchenne muscular dystrophy (mdx), which develops a cardiomyopathy that includes some characteristics of the human disease, to study the molecular basis of this pathology. Here we show that the mdx mouse heart has defects consistent with alteration in compounds that regulate energy homeostasis including a marked decrease in creatine-phosphate (PC). In addition, the mdx heart is more susceptible to anoxia than controls. Since the cardio-protective ATP sensitive potassium channel (KATP) complex and PC have been shown to interact we investigated whether deficits in PC levels correlate with other molecular events including KATP ion channel complex presence, its functionality and interaction with dystrophin. We found that this channel complex is present in the dystrophic cardiac cell membrane but its ability to sense a drop in the intracellular ATP concentration and consequently open is compromised by the absence of dystrophin. We further demonstrate that the creatine kinase muscle isoform (CKm) is displaced from the plasma membrane of the mdx cardiac cells. Considering that CKm is a determinant of KATP channel complex function we hypothesize that dystrophin acts as a scaffolding protein organizing the KATP channel complex and the enzymes necessary for its correct functioning. Therefore, the lack of proper functioning of the cardio-protective KATP system in the mdx cardiomyocytes may be part of the mechanism contributing to development of cardiac disease in dystrophic patients

Sintesi e proprietà fotovoltaiche di politiofeni water- soluble

Nell’ottica di una limitazione dello sfruttamento di fonti fossili, della diminuzione delle emissioni di gas serra e dell’introduzione, nel mercato energetico, di dispositivi fotovoltaici organici (OPVs) che permettano di sfruttare l’energia solare conferendo leggerezza e flessibilità alle celle fotovoltaiche, è stato sintetizzato un nuovo polialchiltiofene contenente unità elettron-donatrici e accettrici in catena principale, da testare come strato fotoattivo all’interno di un dispositivo OPV. In particolare, a partire da 1,6-dibromoesano e 3-bromotiofene, è stato preparato 4,7-bis(3-(6-bromoesil)tiofen-2-il)-2,1,3-benzotiadiazolo mediante reazione di cross-coupling di Suzuki con l’estere pinacolico dell'acido 2,1,3-benzotiadiazolo-4,7-bis(boronico) e, successivamente, polimerizzato via metodo ossidativo con FeCl3. Il polimero ottenuto, poli(4,7-bis(3-(6-bromoesil)tiofen-2-il)-2,1,3-benzotiadiazolo), è stato caratterizzato mediante analisi TGA, DSC, FTIR-ATR, GPC, 1H-NMR e UV-Vis. Verrà, in seguito, post-funzionalizzato con tributilfosfina per ottenere un polimero ionico solubile in acqua o in solventi polari, al fine di evitare l’impiego di solventi aromatici o clorurati durante la deposizione del film polimerico all’interno della cella fotovoltaica